Skip to main content
SpringerLink
Log in

Evidence for involvement of 5-HT1C and 5-HT2 receptors in the food intake suppressant effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Administration of various doses of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) to rats produced dose-related decreases in 1-h food intake in the food-deprived paradigm. Pretreatment with spiperone (5-HT1A/5-HT2/D2 antagonist), propranolol or CGP361A (β-adrenoceptor antagonists that also have binding affinities for 5-HT1A and 5-HT1B sites) and MDL-72222 (5-HT3 antagonist) did not attenuate DOI-induced suppression of food intake. In contrast, pretreatment with metergoline (5-HT1/5-HT2 antagonist) completely blocked whereas mesulergine, mianserin and ritanserin (5-HT1C/5-HT2 antagonists) partially blocked DOI's effect on food intake. On the other hand, pretreatment with MDL-72222 but not with m-chlorophenylpiperazine (m-CPP) significantly potentiated DOI-induced suppression of food intake. Furthermore, the food intake suppressant effects of various doses of DOI were found to be similar in the Fawn-Hooded (FH) rat strain as compared to the Wistar rat strain. These findings suggest that DOI-induced suppression of food intake is mediated by stimulation of both 5-HT1C and 5-HT2 receptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Appel NM, Mitchell WM, Garlick RK, Glennon RA, Teitler M, DeSouza EB (1990) Autoradiographic characterization of (±)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminoproprane ([125I]DOI) binding to 5-HT2 and 5-HT1C receptors in rat brain. J Pharmacol Exp Ther 255:843–857

    Google Scholar 

  • Aulakh CS, Wozniak KM, Hill JL, DeVane CL, Tolliver TJ, Murphy DL (1988) Differential neuroendocrine responses to the 5-HT agonist m-chlorophenylpiperazine in Fawn-Hooded rats relative to Wistar and Sprague-Dawley rats. Neuroendocrinology 48:401–406

    Google Scholar 

  • Aulakh CS, Hill JL, Murphy DL (1989) A comparison of feeding and locomotion responses to serotonin agonists in three rat strains. Pharmacol Biochem Behav 31:567–571

    Google Scholar 

  • Blundell JE (1984) Serotonin and appetite. Neuropharmacology 23:1537–1551

    Google Scholar 

  • Closse A (1983) [3H] mesulergine, a selective ligand for serotonin-2-receptors. Life Sci 32:2485–2595

    Google Scholar 

  • Conn PJ, Sanders-Bush E (1987) Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT2 and 5-HT1C) receptors. J Pharmacol Exp Ther 242:552–557

    Google Scholar 

  • Conn PJ, Sanders-Bush E, Hoffman BJ, Hartig PR (1986) A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover. Proc Natl Acad Sci USA 83:4086–4088

    Google Scholar 

  • Glennon RA, Pierson ME, McKenney JD (1988a) Stimulus generalization of 1-(3-trifluoromethyl-phenyl) piperazine (TFMPP) to propranolol, pindolol and mesulergine. Pharmacol Biochem Behav 29:197–199

    Google Scholar 

  • Glennon RA, Seggel MR, Soine WH, Herrick-Davis K, Lyon RA, Titeler M (1988b) [125I]-1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane: an iodinated radioligand that specifically labels the agonist high-affinity state of 5-HT2 serotonin receptors. J Med Chem 31:5–7

    Google Scholar 

  • Gudelsky GA, Koenig JI, Meltzer HY (1985) Altered responses to serotonergic agents in Fawn-Hooded rats. Pharmacol Biochem Behav 22:489–492

    Google Scholar 

  • Hartig PR (1989) Molecular biology of 5-HT receptors. TIPS 10:64–69

    Google Scholar 

  • Hoffman BJ, Mezey E (1989) Distribution of serotonin 5-HT1C receptor mRNA in adult rat brain. FEBS Lett 247:453–462

    Google Scholar 

  • Hoyer D (1988) Functional correlates of serotonin 5-HT1 recognition sites. J Recept Res 8:59–81

    Google Scholar 

  • Hoyer D, Engel G, Kalkman HO (1985) Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]-5HT, [3H]-8-OHDPAT, (−)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. Eur J Pharmacol 118:13–23

    Google Scholar 

  • Hoyer D, Waeber C, Schoeffter P, Palacios JM, Dravid A (1989) 5-HT1C receptor-mediated stimulation of inositol phosphate production in pig choroid plexus. A pharmacological characterization. Naunyn-Schmiedeberg's Arch Pharmacol 339:252–258

    Google Scholar 

  • Julius D, MacDermott AB, Axel R, Jessell TM (1988) Molecular characterization of a functional cDNA encoding the serotonin 1c receptor. Science 241:558–564

    Google Scholar 

  • Kennett GA, Curzon G (1988a) Evidence that hypophagia induced by m-CPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU24969 only requires 5-HT1B receptors. Psychopharmacology 96:93–100

    Google Scholar 

  • Kennett GA, Curzon G (1988b) Evidence that m-CPP may have behavioral effects mediated by central 5-HT1C receptors. Br J Pharmacol 94:137–147

    Google Scholar 

  • Kilpatrick GJ, Jones BJ, Tyers MB (1987) Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature 330:746–748

    Google Scholar 

  • Kohnen R, Kruger HP (1986) Drug effects on human social behavior: changes in talking activities induced by CGP361A, a beta-blocking agent. Pharmacopsychiatry 19:186–187

    Google Scholar 

  • Leibowitz SF, Shor-Posner G (1986) Brain serotonin and eating behavior. Appetite 7 [Suppl]:1–14

    Google Scholar 

  • Leysen JE, Awouters F, Kennis L, Laduron PM, Vandenberk J, Janssen PAJ (1981) Receptor binding profile of R41468, a novel antagonist of 5-HT2 receptors. Life Sci 28:1015–1022

    Google Scholar 

  • Molineaux SM, Jessell TM, Axel R, Julius D (1989) 5-HT1C receptor is a prominent serotonin receptor subtype in the central nervous system. Proc Natl Acad Sci USA 86:6793–6797

    Google Scholar 

  • Murphy DL, Lesch KP, Aulakh CS, Pigott TA (1991) Serotonin-selective arylpiperazines with neuroendocrine, behavioral, temperature, and cardiovascular effects in humans. Pharmacol Rev 43 [4]:527–552

    Google Scholar 

  • Pritchett DB, Bach AWJ, Wozny M, Taleb O, DalToso R, Shih JC, Seeburg PH (1988) Structure and functional expression of cloned rat serotonin 5-HT2 receptor. EMBO J 7:4135–4140

    Google Scholar 

  • Rittenhouse PA, Bakkum EA, Van de Kar LD (1991) Evidence that the serotonin agonist, DOI, increases renin secretion and blood pressure through both central and peripheral 5-HT2 receptors. J Pharmacol Exp Ther 259:58–65

    Google Scholar 

  • Schechter LE, Simansky KJ (1988) 1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI) exerts an anorexic action that is blocked by 5-HT2 antagonists in rats. Psychopharmacology 94:342–346

    Google Scholar 

  • Simansky KJ, Schechter LE (1988) Properties of somel-arylpiperazines as antagonists of stereotyped behaviors mediated by central serotonergic receptors in rodents. J Pharmacol Exp Ther 247:1073–1081

    Google Scholar 

  • Titeler M, Lyon RA, Glennon RA (1988) Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens. Psychopharmacology 94:213–216

    Google Scholar 

  • Wang P, Aulakh CS, Hill JL, Murphy DL (1988) Fawn-Hooded rats are subsensitive to the food intake suppressant effect of 5-HT agonists. Psychopharmacology 94:558–562

    Google Scholar 

  • Ward JS, Fuller RW, Merritt L, Snoddy HD, Paschal JW, Mason NR, Horng JS (1988) Ergolines as selective 5-HT1 agonists. J Med Chem 31:1512–1519

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Clinical Science, National Institute of Mental Health, Clinical Center, 9000 Rockville Pike, 20892, Bethesda, MD, USA

    Charanjit S. Aulakh, James L. Hill, Hakan T. Yoney & Dennis L. Murphy

Authors
  1. Charanjit S. Aulakh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James L. Hill
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hakan T. Yoney
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dennis L. Murphy
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aulakh, C.S., Hill, J.L., Yoney, H.T. et al. Evidence for involvement of 5-HT1C and 5-HT2 receptors in the food intake suppressant effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI). Psychopharmacology 109, 444–448 (1992). https://doi.org/10.1007/BF02247721

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02247721

Key words

Search

Navigation